Exercise or conversion
Craig C. Hopkinson
EVP R&D, Chief Medical Officer
Ordinary Shares
- Value context
- $122.95K
- Reported price
- $24.59 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Alkermes plc.
Last 30 daysNo qualifying insider buying. Sales: $83.46K by 1 insider.
Showing the first 6 of 20 trades on this page.
EVP R&D, Chief Medical Officer
Ordinary Shares
EVP R&D, Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President & CEO, Alkermes plc
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & CEO, Alkermes plc
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Ordinary Shares
Director
Ordinary Shares
Director
Non Qualified Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Non Qualified Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP R&D, Chief Medical Officer
Ordinary Shares
EVP R&D, Chief Medical Officer
Ordinary Shares
EVP R&D, Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP R&D, Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP R&D, Chief Medical Officer
Ordinary Shares
EVP R&D, Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP R&D, Chief Medical Officer
Ordinary Shares
EVP R&D, Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
VP, Finance (Interim PAO)
Ordinary Shares
VP, Finance (Interim PAO)
Ordinary Shares
VP, Finance (Interim PAO)
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
VP, Finance (Interim PAO)
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP R&D, Chief Medical Officer | Ordinary SharesOption exercise or conversion10b5-1 | 5,000$24.59 / share | $122.95K | Sep 1Filed Sep 1 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Employee Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units5,000$24.59 exercise / conversion price | Not a separate purchase | Sep 1Filed Sep 1 · 0d later | SEC filing |
| President & CEO, Alkermes plc | Employee Stock Option (Right to Buy)Grant or award | Derivative units93,229Award · no purchase price | Non-cash award | Aug 5Filed Aug 7 · 2d later | SEC filing |
| President & CEO, Alkermes plc | Employee Stock Option (Right to Buy)Grant or award | Derivative units124,305Award · no purchase price | Non-cash award | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Director | Ordinary SharesOption exercise or conversion | 27,948$46.72 / share | $1.31M | Aug 3Filed Aug 3 · 0d later | SEC filing |
| Director | Ordinary SharesOption exercise or conversion | 16,524$46.72 / share | $772K | Aug 3Filed Aug 3 · 0d later | SEC filing |
| Director | Non Qualified Stock Option (Right to Buy)Option exercise or conversion | Derivative units27,948$46.72 exercise / conversion price | Not a separate purchase | Aug 3Filed Aug 3 · 0d later | SEC filing |
| Director | Non Qualified Stock Option (Right to Buy)Option exercise or conversion | Derivative units16,524$46.72 exercise / conversion price | Not a separate purchase | Aug 3Filed Aug 3 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Ordinary SharesOption exercise or conversion10b5-1 | 104$19.34 / share | $2.01K | Aug 3Filed Aug 3 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Ordinary SharesOption exercise or conversion10b5-1 | 4,896$24.59 / share | $120.39K | Aug 3Filed Aug 3 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Employee Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units104$19.34 exercise / conversion price | Not a separate purchase | Aug 3Filed Aug 3 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Employee Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units4,896$24.59 exercise / conversion price | Not a separate purchase | Aug 3Filed Aug 3 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Ordinary SharesOption exercise or conversion10b5-1 | 5,000$19.34 / share | $96.7K | Jul 1Filed Jul 1 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Employee Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units5,000$19.34 exercise / conversion price | Not a separate purchase | Jul 1Filed Jul 1 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Ordinary SharesOption exercise or conversion10b5-1 | 5,000$19.34 / share | $96.7K | Jun 1Filed Jun 1 · 0d later | SEC filing |
| EVP R&D, Chief Medical Officer | Employee Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units5,000$19.34 exercise / conversion price | Not a separate purchase | Jun 1Filed Jun 1 · 0d later | SEC filing |
| VP, Finance (Interim PAO) | Ordinary SharesOption exercise or conversion | 3,392$20.03 / share | $67.94K | May 29Filed May 29 · 0d later | SEC filing |
| VP, Finance (Interim PAO) | Ordinary SharesOption exercise or conversion | 12,825$19.34 / share | $248.04K | May 29Filed May 29 · 0d later | SEC filing |
| VP, Finance (Interim PAO) | Employee Stock Option (Right to Buy)Option exercise or conversion | Derivative units3,392$20.03 exercise / conversion price | Not a separate purchase | May 29Filed May 29 · 0d later | SEC filing |
| VP, Finance (Interim PAO) | Employee Stock Option (Right to Buy)Option exercise or conversion | Derivative units12,825$19.34 exercise / conversion price | Not a separate purchase | May 29Filed May 29 · 0d later | SEC filing |
Showing the latest 20 of 71 trades. Show all 71 trades
Alkermes plc - Ordinary Shares (ALKS) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.